FIELD: organic chemistry, pharmacy. SUBSTANCE: invention describes new derivatives of hydroxymethyl-furazan carboxylic acid of the general formula (I) where one of radicals R1 and R2 means hydroxymethyl and another means -X being X means NR3R4 or OH or OR7; R3 and R4 mean independently each of other hydrogen atom, (C1-C20)-alkyl, 1-phenyl-(C2-C4)-alkyl, 2-phenyl-(C3-C4)-alkyl, (C3-C6)-alkenyl, (C3-C7)-cyclo-alkyl, or , -(CH2)n; or both R3 and R4 in common with binding nitrogen atom form heterocycle that can be once or multiple substituted with (C1-C6)-alkyl, (C3-C7)-cycloalkyl, (C1-C4)- -alkoxy-group, amino-group, (C1-C4)-alkylamino-group, di-((C1-C4)-alkyl)-amino-group, hydroxyl group, benzyl, phenethyl or phenyl; R5 and R6 independently each of other mean hydrogen atom, (C1-C6)-alkyl, (C3-C7)-cycloalkyl, benzyl, phenethyl or phenyl; R7 means (C1-C6)-alkyl, (C3-C7)-cycloalkyl, benzyl, phenyl that can be once or multiple substituted with -alkyl; ALK means (C1-C6)-alkyl; Ar means phenyl that can be once or multiple substituted with (C1-C4)-alkyl, (C1-C4)-alkoxy-group, sulfamoyl; Het is a heterocyclic radical with 1-3 nitrogen atoms that can be aromatic, partially unsaturated or saturated and can be once or multiple substituted with (C1-C4)-alkyl also; n = 0, 1, 2, 3 or 4; m = 1, 2, 3 or 4; p = 1, 2 or 3 and their pharmaceutically acceptable salts also. New compounds of the formula (I) show valuable pharmacological properties associated with nitrogen oxide formation and its effect for treatment and prophylaxis of cardiovascular system disease. Invention describes a pharmaceutical preparation based on the above indicated compounds showing dilating effect on ocular muscles. EFFECT: improved method of synthesis, valuable pharmacological properties of compounds. 10 cl, 40 ex
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED 6- AND 7-AMINOTETRAHYDROISOQUINOLINE CARBOXYLIC ACIDS | 1998 |
|
RU2212405C2 |
SUBSTITUTED DIAMINOCARBOXYLIC ACIDS | 1998 |
|
RU2196768C2 |
DIHYDROPYRIDINE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1992 |
|
RU2086548C1 |
CYCLIC AND HETEROCYCLIC N-SUBSTITUTED αIMINO HYDROXAMIC AND CARBOXYLIC ACIDS | 1996 |
|
RU2164914C2 |
PREPARATION FOR INHIBITING GLUCOSO-6-PHOSPHATASE SYSTEM FROM MAMMALIAN LIVER | 1993 |
|
RU2131248C1 |
METALLOCENES WITH BENZOFUSED INDENYL DERIVATIVES, METHOD OF THEIR SYNTHESIS, METHOD OF OLEFIN POLYMER PRODUCING AND CATALYST FOR OLEFIN POLYMERIZATION | 1992 |
|
RU2098423C1 |
SUBSTITUTED DERIVATIVES OF PURINE, METHODS FOR THEIR PREPARING AND PHARMACEUTICAL PREPARATION | 1997 |
|
RU2228335C2 |
TARTRATE DERIVATIVES APPLIED AS BLOOD COAGULATION FACTOR IXA INHIBITORS | 2007 |
|
RU2446160C2 |
SUBSTITUTED AZOLES AND A METHOD OF THEIR SYNTHESIS | 1991 |
|
RU2047604C1 |
ISOSERINE DERIVATIVES APPLIED AS BLOOD COAGULATION FACTOR IXA INHIBITORS | 2007 |
|
RU2446157C2 |
Authors
Dates
1999-08-20—Published
1994-02-18—Filed